Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), sold 100,000 shares at $109.60 ($10.9M) on 2022-07-26, disclosed to the SEC on 2022-07-28.
Open-market sale of $10.9M ABT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.77 | 27,749 | $3.0M | 27.7% |
| 2 | $108.77 | 27,749 | $3.0M | 27.7% |
| 3 | $109.60 | 22,251 | $2.4M | 22.3% |
| 4 | $109.60 | 22,251 | $2.4M | 22.3% |
| Total | $109.14 avg | 100,000 | $10.9M | 100% |
| Filing → |
| ABT | SELL | 2023-10-30 | $9.4M | — | Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |